Table 3.
Cancer | Sex | Mortality rate, US average** | UVB dose (β, p) | Lung cancer (β, p) | Alcohol consumption (β, p) | Urban residence (β, p) | Adjusted R2, p |
All less lung | M | 140.07 | −0.50* | 0.55* | 0.27* | 0.17* | 0.52* |
F | 111.95 | −0.68* | 0.38* | 0.09, 0.005 | 0.20* | 0.67* | |
Bladder | M | 6.56 | −0.51* | 0.33* | 0.31* | 0.21* | 0.47* |
F | 1.87 | −0.37* | 0.45* | 0.09, 0.04 | 0.07, 0.09 | 0.36* | |
Breast | F | 26.89 | −0.57* | 0.28* | 0.15* | 0.20* | 0.57* |
Cervical | F | 3.22 | −0.10, 0.02 | 0.26* | −0.22* | −0.02, 0.76 | 0.09* |
Colon | M | 20.13 | −0.65* | 0.32* | 0.06, 0.09 | 0.33* | 0.50* |
F | 14.97 | −0.68* | 0.23* | −0.07, 008 | 0.23* | 0.50* | |
Endometrial | F | 3.72 | −0.58* | −0.04, 0.26 | −0.05, 0.29 | 0.38* | 0.42* |
Esophageal | M | 4.80 | −0.49* | 0.33* | 0.33* | 0.16* | 0.44* |
F | 1.24 | −0.14* | 0.54* | 0.22* | 0.03, 0.48 | 0.42* | |
Gallbladder | M | 0.57 | −0.28* | −0.16* | 0.01, 0.82 | 0.19* | 0.16* |
F*** | 1.10 | −0.56* | −0.25* | −0.08, 0.12 | 0.14, 0.003 | 0.41* | |
Gastric*** | M | 7.33 | −0.41* | −0.04, 0.46 | 0.14, 0.007 | 0.14, 0.009 | 0.33* |
F | 3.41 | −0.29* | −0.001, 0.98 | 0.17, 0.003 | 0.10, 0.08 | 0.20* | |
Hodgkin's | M | 1.10 | −0.29* | 0.01, 0.78 | −0.10, 0.07 | 0.08, 0.13 | 0.07* |
F | 0.67 | −0.31* | 0.08, 0.06 | 0.05, 0.28 | 0.09* | ||
Laryngeal | M | 2.49 | −0.20* | 0.67* | 0.14, 0.001 | 0.10, 0.02 | 0.41* |
F | 0.42 | −0.09, 0.11 | 0.56* | 0.02, 0.67 | 0.05, 0.25 | 0.33* | |
Leukemia | M | 8.80 | −0.18* | 0.11, 0.03 | −0.12, 0.02 | 0.15, 0.005 | 0.04* |
F | 5.16 | −0.17* | −0.01, 0.82 | −0.14, 0.01 | 0.13, 0.01 | 0.03, 0.001 | |
Melanoma | M | 2.96 | 0.42* | 0.28* | 0.02, 0.62 | 0.07, 0.14 | 0.27* |
F | 1.61 | 0.39* | 0.13, 0.002 | −0.14, 0.001 | 0.18* | ||
Multiple myeloma | M | 3.10 | −0.18* | −0.10, 0.03 | −0.05, 0.36 | −0.05, 0.34 | 0.04* |
F | 2.08 | −0.22* | 0.008, 0.86 | 0.07, 0.18 | −0.05, 0.39 | 0.05* | |
NHL | M | 7.03 | −0.41* | 0.11, 0.01 | 0.03, 0.55 | 0.17, 0.001 | 0.18* |
F | 4.76 | −0.40* | 0.08, 0.05 | −0.06, 0.23 | 0.12, 0.02 | 0.15* | |
NMSC | M | 1.17 | 0.37* | 0.47* | −0.02, 0.59 | −0.11, 0.009 | 0.44* |
M*** | 1.17 | 0.36* | 0.41* | 0.04, 0.41 | −0.11, 0.01 | 0.46* | |
F | 0.43 | 0.15, 0.001 | 0.23* | −0.16, 0.002 | −0.13, 0.01 | 0.12* | |
F*** | 0.43 | 0.27* | 0.16, 0.001 | −0.13, 0.03 | −0.04, 0.44 | 0.16* | |
Other oral and pharynx | M | 3.99 | −0.10, 0.007 | 0.61* | 0.24* | 0.10, 0.02 | 0.34* |
F | 1.41 | 0.12, 0.001 | 0.60* | 0.16* | −0.10, 0.01 | 0.41* | |
Ovarian | F | 8.38 | −0.59* | 0.08, 0.02 | 0.10, 0.02 | 0.22* | 0.43* |
Pancreatic | M | 10.21 | 0 | 0.36* | 0.15, 0.005 | −0.11, 0.04 | 0.13 * |
F | 6.84 | −0.05, 0.24 | 0.28* | 0.27* | 0.01, 0.77 | 0.13* | |
Prostate | M | 22.01 | −0.21* | −0.17* | 0.30* | −0.23* | 0.18* |
Rectal | M | 4.40 | −0.64* | 0.14* | 0.25* | 0.24* | 0.57* |
F | 2.54 | −0.59* | 0.19* | 0.19,* | 0.24* | 0.57* | |
Renal | M | 4.90 | −0.35* | 0.20* | 0.05, 0.34 | 0.07, 0.18 | 0.14* |
F | 2.24 | −0.38* | 0.08, 0.06 | 0.04, 0.41 | −0.02, 0.66 | 0.15* | |
Thyroid | M | 0.33 | −0.11, 0.02 | −0.11, 0.02 | −0.09, 0.09 | 0.11, 0.04 | 0.02* |
F | 0.42 | −0.14, 0.002 | −0.08, 0.06 | 0.19* | 0.05* | ||
Vulva | F | 0.34 | −0.43* | −0.05, 0.27 | 0.10, 0.01 | 0.20* |
M, male; F, female. *p < 0.001; **, deaths/100,000/year; ***, UVB dose limited to <7.5 kJ/m2; β, normalized regression coefficient.